PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Descovy. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

7 hits

Bibliografisk träff 2016-11-01

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.

Gallant J, Brunetta J, Crofoot G, Benson P, Mills A, Brinson C, Oka S, Cheng A, Garner W, Fordyce M, Das M, McCallister S, GS-US-292-1249 Study Investigators.

J Acquir Immune Defic Syndr · clinical trial, phase iii; brief-report; multicenter study; journal article · DOI 10.1097/qai.0000000000001069

Bibliografisk träff 2016-08-01

Emtricitabine/tenofovir alafenamide (Descovy) for HIV.

Författaruppgift saknas

Med Lett Drugs Ther · journal article

Bibliografisk träff 2016-07-27

Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection.

Massud I, Mitchell J, Babusis D, Deyounks F, Ray AS, Rooney JF, Heneine W, Miller MD, García-Lerma JG.

J Infect Dis · journal article · DOI 10.1093/infdis/jiw312

Bibliografisk träff 2016-06-01

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.

Greig SL, Deeks ED.

Drugs · review; journal article · DOI 10.1007/s40265-016-0586-z

Bibliografisk träff 2016-04-01

[Brief notes. Approval recommendation for fixed combination Descovy(R) in treatment of HIV].

Red.

MMW Fortschr Med · journal article

Bibliografisk träff 2016-03-01

Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.

Margot NA, Kitrinos KM, Fordyce M, McCallister S, Miller MD, Callebaut C.

HIV Clin Trials · clinical trial, phase iii; clinical trial, phase ii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1080/15284336.2016.1142731

Bibliografisk träff 2016-01-01

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults.

Bonora S, Calcagno A, Trentalange A, Di Perri G.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2016.1129401